GSK plc (BCBA:GSK)

Argentina flag Argentina · Delayed Price · Currency is ARS
12,175
+25 (0.21%)
At close: Jul 8, 2025, 5:00 PM BRT
-12.44%
Market Cap 97.54T
Revenue (ttm) 43.71T
Net Income (ttm) 4.37T
Shares Out n/a
EPS (ttm) 1,055.37
PE Ratio 22.31
Forward PE 8.26
Dividend 382.63 (3.18%)
Ex-Dividend Date May 16, 2025
Volume 47
Average Volume 314
Open 12,250
Previous Close 12,150
Day's Range 12,075 - 12,325
52-Week Range 9,110 - 14,400
Beta n/a
RSI 60.17
Earnings Date Jul 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a... [Read more]

Industry Pharmaceutical Preparations
Founded 1715
Employees 68,629
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol GSK
Full Company Profile

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.